Nivalis Therapeutics Inc (NASDAQ: NVLS) shares rocketed 5.2% to $2.32, as the company disclosed that it is exploring strategic alternatives for the company and has engaged Ladenburg Thalmann to act as an advisor. Share volume was 634,000, compared to an all-day average of 353,000
